Efficacy & Safety of Submucosal Endoscopic Myotomy With Mucosal Flap (SEMF) in the Treatment of Patients With Achalasia
NCT01438398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2017-05-11
Summary
The purpose of this study is to learn about the safety and usefulness of a procedure called endoscopic submucosal myotomy, which is a new technique in the treatment of achalasia. Achalasia is a disorder involving the lack of smooth muscle relaxation and sustained high pressure in the sphincter (muscle) of the lower esophagus. This may result in symptoms such as difficulty in swallowing, chest pain, regurgitation of food and eventually, weight loss.
For more than a decade, a laparoscopic surgical procedure known as Heller myotomy has been the primary treatment for achalasia in patients with low surgical risk. In Heller myotomy, the surgeon makes three to four small abdominal incisions, inserts tube-like instruments through them, and once inside, the junction between the esophagus and stomach is found, a lengthwise incision is made on the muscular ring surrounding the lower esophageal sphincter which weakens the muscle and the lower esophageal sphincter or muscle (LES) is then able to open more easily. However, there is an emerging field known as natural orifice (opening) transluminal (through the lumen) endoscopic surgery (NOTES). This approach involves passing an endoscope - a thin tube with a built-in camera, light and minuscule tools through the natural opening in the body, like the mouth in order to perform less invasive surgery without any external wounds or scars. The procedure is done using the Submucosal Endoscopy with Mucosal Flap (SEMF) technique which involves passing an endoscope through the mouth into the esophagus, where a small incision is made on the lining of the esophagus, known as the mucosa. A balloon is then inserted and dilated in the submucosa - the layer between the inner lining of the esophagus and the outer wall consisting of the muscle of the esophagus. Dilation of the balloon in the submucosa creates a tunnel that allows insertion of the endoscope and access to the muscle of the lower esophageal sphincter (LES). A long incision is then carefully made on the posterior portion of the muscular ring that forms the LES. The incision divides the muscle fibers of the LES, which weakens the muscle, allowing for the easier passage of food while preserving some valve function to prevent reflux of acid from the stomach into the esophagus.
The expected duration of participation is up to 10 years from the time study participants undergo the endoscopic surgical procedure.
Conditions
- Achalasia
- Dysphagia
Interventions
- PROCEDURE
-
Submucosal endoscopic myotomy with mucosal flap technique
Submucosal Endoscopy with Mucosal Flap (SEMF) technique involves the following: (1) injecting 0.9 % normal saline solution to create a submucosal cushion, (2) tiny cut is made into the cushion, (3) Balloon will be used to dilate the opening and allow passage of endoscope in the submucosal space, (4) Upon direct visualization of the muscle fibers, the doctor will cut the circular layers of the diseased muscles, and (5) Tiny clips will be used to close the tiny cut made earlier.
- PROCEDURE
-
Submucosal Endoscopic Mucosal Flap (SEMF) technique
Sponsors & Collaborators
-
Winthrop University Hospital
lead OTHER
Principal Investigators
-
Stavros N Stavropoulos, MD · Winthrop University Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-04-08
- Primary Completion
- 2015-01-06
- Completion
- 2015-10-22
Countries
- United States
Study Locations
More Related Trials
-
ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia
NCT04065516 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Do Patients Who Have Had Surgery for Achalasia Suffer From Reflux
NCT00519441 ·Status: COMPLETED ·Phase: NA
-
Radiofrequency Ablation for the Treatment of Large Symptomatic Heterotopic Gastric Mucosa
NCT03518905 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Two Therapies for Upper Esophageal Sphincter (UES) Dysphagia
NCT00059670 ·Status: COMPLETED ·Phase: NA
-
To Investigate the Incidence of Reflux in Patients After Per-oral Endoscopic Myotomy in Achalasia Cardia Patients
NCT04951739 ·Status: COMPLETED
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Laryngopharyngeal Reflux Before and After Cricopharyngeal Myotomy
NCT01880892 ·Status: COMPLETED ·Phase: NA
-
Impact of Blocking the Glossopharyngeal Nerve on Gastroesophageal Reflux Disease
NCT06304870 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Method of Early Diagnosis of Laryngopharyngeal Reflux
NCT04771221 ·Status: COMPLETED ·Phase: NA
-
Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia
NCT02959450 ·Status: COMPLETED ·Phase: NA
-
Whether Proton Pump Inhibitors, Administered Prior to or After Surgery, Can Reduce the Incidence and/or Severity of Difficulty Swallowing Foods and/or Liquids,Following Anterior Cervical Surgery
NCT03488147 ·Status: WITHDRAWN ·Phase: PHASE2
-
Esophageal Impedance and Manometry Measurements and Dysphagia Symptom Scoring
NCT04503785 ·Status: RECRUITING
-
Topical Bethanechol for Improvement of Esophageal Dysmotility
NCT01031043 ·Status: COMPLETED ·Phase: PHASE1
-
Diagnostic Evaluation of Esophageal Motility Disorders Using the Chicago IV Protocol in Egypt
NCT06878586 ·Status: NOT_YET_RECRUITING
-
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
NCT06883175 ·Status: RECRUITING ·Phase: NA
-
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
NCT02353078 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prevalence and Clinical Characteristics of Patients With Jackhammer Esophagus and Symptoms of Gastroesophageal Reflux Disease
NCT03347903 ·Status: COMPLETED
-
Allergy Immunotherapy in the Management of Eosinophilic Esophagitis
NCT01685034 ·Status: WITHDRAWN ·Phase: NA
-
Antireflux Ablation Therapy (ARAT) Vs Antireflux Mucosectomy (ARMS) In The Management Of Gastroesophageal Reflux Disease
NCT04036942 ·Status: WITHDRAWN ·Phase: NA
-
Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery
NCT01241149 ·Status: TERMINATED ·Phase: NA
-
One-stop-shop Endoscopy in Reflux-patients: Evaluation of ENT and GI Features
NCT05634187 ·Status: COMPLETED
-
Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease
NCT06215794 ·Status: WITHDRAWN ·Phase: NA
-
Anti-Reflux Mucosectomy in the Treatment of Refractory Gastro-esophageal Reflux
NCT05745012 ·Status: RECRUITING ·Phase: NA
-
Effect of Azithromycin on Oesophageal Hypomotility
NCT01448993 ·Status: COMPLETED ·Phase: PHASE2
-
Interpretation of Transnasal Esophagoscopy Findings
NCT00372918 ·Status: COMPLETED ·Phase: PHASE4